About 7 results found for searched term "GSK232" (0.052 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2171 | GSK923295 | Kinesin |
| GSK923295 is an allosteric inhibitor of CENP-E with Ki value of 3.2 nM. | ||
| M3715 | GSK2838232A | HIV Protease |
| GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection. | ||
| M11004 | GSK-2324 | Others |
| GSK2324 is a FXR agonist with EC50 value of 50 nM. | ||
| M21277 | GSK232 | Epigenetic Reader Domain |
| GSK232 is a highly selective inhibitor of cell permeation of non-BET CECR2 brominated structures with >500-fold selectivity for BET family brominated structures. | ||
| M24604 | Ozanezumab | Others |
| GSK1223249 | ||
| Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research. | ||
| M27856 | Lanopepden | Antibiotic |
| GSK 1322322 | ||
| Lanopepden (GSK 1322322) is a peptide deformylase inhibitor active against Staphylococcus aureus strains with MICs of 1 and 1 mg/L for ATCC 29213 and ATCC 25923 strain, respectively. | ||
| M28448 | GSK2838232 | HIV Protease |
| GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
